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viable, but conditional strategies to inacti-
vate SIRT1 spatially or temporally may be 
 applicable.
Weismann recognized that his concept 
of the germ line could explain how nature 
trumped aging, at least at the species 
level. The findings of Liu et al. provide a 
molecular framework for how this crucial 
process can occur, and could eventually 
lead to new strategies to slow aging in the 
soma. A weight of evidence already indi-
cates that SIRT1 protects somatic cells 
against aging by deacetylating factors 
regulating metabolic pathways, stress 
tolerance, and genomic stability (Fin-
kel et al., 2009). This effect is enhanced 
when precious resources are shifted 
from germ line maintenance to somatic 
cell maintenance during food scarcity 
(Kirkwood, 1977). Under these condi-
tions, the premium may be on delaying 
reproduction until food becomes more 
available. The study by Liu et al. raises 
the fascinating possibility that SIRT1 is 
also called into action to promote germ 
cell quality control when resources are 
plentiful, that is, during times of food 
abundance.
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How does a cell in mitosis cope with a 
broken chromosome? According to find-
ings presented by Royou et al. (2010) 
in this issue, neuroblasts in the fruit fly 
Drosophila have the capacity to reattach 
the broken pieces with thin tethers that 
contain DNA and some familiar mitotic 
proteins. Remarkably, in many cases, 
this emergency fix lasts long enough to 
allow the completion of cell division and 
can even rescue larval development.
In mitosis two sister kinetochores are 
built at the centromeres of each chromo-
some. The kinetochores attach to the 
mitotic spindle microtubules and move 
the chromosomes to align them at the 
metaphase plate. Then, at anaphase 
each chromosome separates into two 
chromatids that are ferried to opposite 
poles by kinetochores. Given the promi-
nence of kinetochores in chromosome 
segregation, conventional wisdom sug-
gests that chromosome fragments lack-
ing centromeres would fail to segregate 
properly during mitosis. However, some 
studies report that the segregation of 
chromosome fragments lacking cen-
tromeres is remarkably resilient over 
several cell divisions (Malkova et al., 
1996; Titen and Golic, 2008).
To create acentric chromosome frag-
ments under controlled conditions, 
Royou et al. expressed I-CreI endonu-
clease under the control of a heat shock 
promoter in third instar larvae. I-CreI 
induces a double-strand break at an 
endogenous 20 nucleotide sequence 
within the ribosomal DNA located on 
Drosophila sex chromosomes. As a con-
sequence, I-CreI expression causes the 
Drosophila X chromosome to break into 
two pieces, a small fragment containing 
the centromere and a long acentric chro-
mosome arm. Remarkably, the acen-
tric fragments segregate successfully 
through multiple rounds of cell division, 
and their induction causes no detect-
able impairment in the development of 
third instar larvae into adult flies (though 
I-CreI expression does cause significant 
lethality when induced at earlier stages).
The authors examined larval neuro-
blasts expressing I-CreI by cytology and 
fluorescence video microscopy and find 
that they exhibit normal chromosomal 
alignment at metaphase. However, at 
anaphase there are a few lagging chro-
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A cell undergoing mitosis is presented with a potentially catastrophic situation when a DNA double-
strand break creates a chromosome fragment that lacks connection to a centromere. Royou et al. 
(2010) now reveal that this cellular crisis is averted in fruit fly neuroblasts by thin chromatin tethers 
that hold on to the ends of the broken chromosomes.
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matids that are shown to be acentric 
fragments of the X chromosome. After 
a few minutes most acentric fragments 
do eventually move and most are segre-
gated appropriately to opposite poles, 
thus preserving the normal DNA content 
in the daughter cells (Figure 1).
In the absence of centromeres and 
thus kinetochores, how are the acentric 
fragments able to move to the meta-
phase plate and eventually segregate 
appropriately, and what might account 
for their high frequency of successful 
segregation to opposite poles? Although 
we do not have the complete answers to 
these questions, the findings reported 
by Royou et al. reveal important and 
intriguing leads. The first clue comes 
from detailed cytological observations 
of the X chromosomes in cells with the 
I-CreI-induced double-strand breaks. In 
the majority of cells very thin chromatin 
strands, termed “tethers” by the authors, 
connect the acentric chromosome frag-
ments to the centric fragments. Immu-
nolabeling and expression of proteins 
tagged with green fluorescent protein 
(GFP) show that these tethers contain 
concentrations of several important 
mitotic proteins including Polo, Aurora-B, 
INCENP, and BubR1. Polo and Aurora-B 
are both kinases that participate in many 
aspects of mitosis and cytokinesis, and 
INCENP is a binding partner and activa-
tor of Aurora-B (Archambault and Glover, 
2009; Ruchaud et al., 2007). BubR1 is a 
large protein kinase with more special-
ized roles in chromosome movement 
and in the mitotic spindle checkpoint 
that inhibits anaphase onset until chro-
mosomes are properly aligned at meta-
phase (Huang and Yen, 2009). A unifying 
characteristic of these proteins is that 
they are normally concentrated in early 
mitosis at the centromere/kinetochore 
region. However, given that other mitotic 
centromere/kinetochore proteins such 
as Cid/CenpA or Mad2 are not detect-
ably enriched on the tethers, the authors 
conclude that the observed phenom-
enon is not due to the induction of new 
centromeres, a mechanism that occurs 
in certain circumstances on acentric 
chromosome fragments.
Do the proteins concentrated on the 
tethers have functional roles in the seg-
regation of acentric fragments? Evidence 
from studies of mutant flies suggests 
that this is case for Polo and BubR1. 
Flies with certain hypomorphic muta-
tions in genes encoding these proteins 
have little effect on survival to adulthood. 
However, when combined with I-CreI 
expression within third instar larvae, 
viability is greatly compromised. Close 
examination of these flies reveals that 
their acentric fragments are more likely 
to lack tethers and to exhibit a delay in 
anaphase segregation or completely fail 
to segregate. Moreover, when the acen-
tric fragments do segregate, they more 
frequently fail to move to opposite poles 
resulting in a high percentage of daugh-
ter cells with abnormal chromosome 
content. Although the synthetic effects 
from the mutations might result from 
Polo and BubR1 activities that are inde-
pendent of the tethers, the evidence for 
a more direct role is intriguing.
Many questions remain. Lacking kine-
tochores, how do acentric fragments 
congress to the metaphase plate? Pos-
sible mechanisms include the tethers 
themselves, or perhaps there are inde-
pendent mechanisms of transport, such 
as ejection forces from the spindle pole or 
motor proteins associated with chroma-
tin (chromokinesins). How do the tethers 
facilitate segregation in late anaphase? A 
mechanism proposed by the authors is 
that the acentric fragments move pole-
ward at late anaphase because of the 
elasticity of the chromatin tethers result-
ing from stretching. Once they disen-
tangle from each other, the acentric frag-
ments could then be pulled to the poles. 
If so, what holds the acentric fragments 
together during early anaphase when the 
normal chromatids and the centric frag-
ments separate and move poleward? 
The authors hypothesize that compo-
nents of the DNA repair machinery hold 
the acentric fragments together. How-
ever, DNA catenation is an equally likely 
possibility. Poleward tension imposed by 
the elasticity of the tethers in anaphase 
may be essential to favor decatenation of 
sister acentric fragments by the enzyme 
DNA topoisomerase II and thus might 
account for the delayed separation. The 
final and perhaps most important ques-
tion is how do the tethers form? At this 
point, it is anyone’s guess. The authors 
of the study speculate that the forma-
tion of tethers could involve unresolved 
replication intermediates or DNA repair 
machinery recruited to the break site.
DNA-containing, tether-like strands 
connecting chromosomes and chromo-
some fragments have been reported in a 
number of studies of mitosis and meio-
sis and may be far more widespread 
than previously appreciated (Chan et al., 
2007; LaFountain et al., 2002). In addi-
figure 1. the Rescue of chromosome Breaks in mitosis by chromatin tethers
(Left) Normal metaphase and anaphase segregation of an intact X chromosome of the fruit fly Drosophila. 
(Center) Double-strand chromosome breaks in the Drosophila X chromosome would normally result in 
failure to segregate the fragments lacking connection to the centromeres. (Right) However, in many in-
stances, the appearance of elastic chromatin tethers (red) allows acentric fragments to exhibit a delayed 
but successful segregation to opposite spindle poles (Royou et al., 2010).
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tion, recent studies have linked DNA 
damage and mitotic spindle check-
points, previously regarded, at least out-
side yeast, as relatively distinct signaling 
pathways (Choi and Lee, 2008; Musaro 
et al., 2008). The study by Royou et al. 
provides a peek into the repair kit for 
mitotic chromosomes. In it we find some 
familiar tools, adapted for unexpected 
applications. Delving further to charac-
terize the complete toolkit will undoubt-
edly reveal additional surprises.
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Comprehensive multidimensional analy-
sis of cancer genomes has revealed a 
staggering level of complexity and vari-
ability even within tumors of the same 
histopathological subtype. These data 
highlight the breadth and depth of the 
constellation of genomic alterations in 
cancer. Although canonical signaling 
pathways seem to be universally deregu-
lated in cancer (Cancer Genome Atlas 
Research Network, 2008), different com-
ponents of a pathway can be altered in 
different tumors. This variability affects 
tumor responses to targeted therapies 
and could explain the limited activity 
observed clinically when targeted thera-
pies are deployed across a group of can-
cer patients with the same histopatho-
logical subtype of tumor. Hence, great 
effort is being devoted to designing and 
developing therapeutic regimens tailored 
to patients whose tumors carry particular 
molecular features. A marquee example 
is the drug trastuzumab, used for treating 
breast cancer. Patients with breast tumors 
harboring amplification or overexpression 
of the HER2/NEU gene, the target of tras-
tuzumab, are more likely to show a clini-
cal response than patients with tumors 
that do not (Smith et al., 2007). But not 
all patients with such signature mutations 
show clinical benefit. One study reported 
that only six out of 100 breast cancer 
patients whose tumors carried HER2 
amplification or overexpression derived 
survival benefits from trastuzumab treat-
ment (Smith et al., 2007). Therefore, 
understanding what dictates responsive-
ness to therapy in the clinic is one of the 
greatest challenges the oncology com-
munity faces, with significant medical and 
economic implications.
Now Heidorn et al. (2010), reporting in 
this issue, identify a new mechanism that 
underlies differential biochemical respon-
siveness to a targeted cancer therapy. 
They show, in melanoma, that drugs that 
specifically inhibit the oncogene BRAF are 
effective in the subpopulation of melano-
mas (?45%) harboring BRAF mutations. 
However, of concern, they discovered 
that these drugs also unleash cancer-
promoting effects in melanomas that har-
bor mutations in the RAS oncogene.
These findings may come as a sur-
prise, as the signaling proteins RAS and 
RAF are depicted as components of the 
same pathway, and RAF is in fact con-
sidered to be an immediate downstream 
signaling surrogate for RAS in the lin-
ear ERK activation cascade. That said, 
groundwork hinting at the complex inter-
play between RAS and RAF has been 
laid by studies on the role of CRAF in 
melanoma. RAS proteins (NRAS, KRAS, 
and HRAS) directly activate RAF pro-
teins (ARAF, BRAF, and CRAF) as part 
of the oncogenic RAS-RAF-MEK-ERK 
signal transduction cascade. The key 
the Brothers RAf
Lawrence N. Kwong1 and Lynda Chin1,2,3,*
1Department of Medical Oncology
2Belfer Institute for Applied Cancer Science
Dana-Farber Cancer Institute, Boston, MA 02115, USA
3Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA
*Correspondence: lynda_chin@dfci.harvard.edu
DOI 10.1016/j.cell.2010.01.013
Targeted molecular therapies for cancer treatment have shown promise, but also have limita-
tions. In this issue, Heidorn et al. (2010) find that a class of targeted molecular therapies 
with clinical effectiveness against one melanoma subtype may have adverse clinical effects in 
another.
